Compounds 3 and 8 displayed both radical scavenging activity and α-glycosidase or PTP1B inhibition activity, which suggests that they could be used as lead compounds to generate potent drugs for the treatment of oxidative stress-related diabetes. The gene discussed is PTPN1; the disease is diabetes mellitus.